OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 280-280
Open Access | Times Cited: 18
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 280-280
Open Access | Times Cited: 18
Showing 18 citing articles:
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment
M. Helena Vasconcelos, Andreia Palmeira, Sofia Martins Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1171-1195
Closed Access | Times Cited: 18
M. Helena Vasconcelos, Andreia Palmeira, Sofia Martins Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1171-1195
Closed Access | Times Cited: 18
Drug repurposing—an emerging strategy in cancer therapeutics
Khadija Shahab Turabi, Ankita Jaywant Deshmukh, Sayan Paul, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 10, pp. 1139-1158
Closed Access | Times Cited: 26
Khadija Shahab Turabi, Ankita Jaywant Deshmukh, Sayan Paul, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 10, pp. 1139-1158
Closed Access | Times Cited: 26
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin
Helena Branco, Júlio Oliveira, Catarina Antunes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3631-3631
Open Access | Times Cited: 20
Helena Branco, Júlio Oliveira, Catarina Antunes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3631-3631
Open Access | Times Cited: 20
Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients
Eric W. Hewitt, Gauthier Bouche, Alexandre Alencar, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 429-440
Open Access
Eric W. Hewitt, Gauthier Bouche, Alexandre Alencar, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 429-440
Open Access
Special Issue: “Drug Repurposing for Cancer Therapies”
Cristina P. R. Xavier, Andreia Palmeira
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1092-1092
Open Access | Times Cited: 3
Cristina P. R. Xavier, Andreia Palmeira
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1092-1092
Open Access | Times Cited: 3
Golgi-Targeting Anticancer Natural Products
Myat Nyein Khine, Kaori Sakurai
Cancers (2023) Vol. 15, Iss. 7, pp. 2086-2086
Open Access | Times Cited: 7
Myat Nyein Khine, Kaori Sakurai
Cancers (2023) Vol. 15, Iss. 7, pp. 2086-2086
Open Access | Times Cited: 7
Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future
J. J. Li, Xiaodong Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 164-213
Closed Access | Times Cited: 2
J. J. Li, Xiaodong Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 164-213
Closed Access | Times Cited: 2
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
Ahmad H. Ali, Ugo Chianese, Chiara Papulino, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3799-3799
Open Access | Times Cited: 8
Ahmad H. Ali, Ugo Chianese, Chiara Papulino, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3799-3799
Open Access | Times Cited: 8
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma
Sofia Martins Sousa, Helena Branco, Amir Avan, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 4, pp. 585-597
Open Access
Sofia Martins Sousa, Helena Branco, Amir Avan, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 4, pp. 585-597
Open Access
Lipid Aging Clocks as predictive and prognostic biomarker in cancer and inflammaging
Maximilian Unfried, Amaury Cazenave‐Gassiot, Evelyne Bischof, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Maximilian Unfried, Amaury Cazenave‐Gassiot, Evelyne Bischof, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Recent Advances and Challenges in Targeted Drug Delivery Using Biofunctional Coatings
Tuğba Bal, Nasma Anjrini, Meryem Zeroual
Royal Society of Chemistry eBooks (2024), pp. 41-75
Closed Access
Tuğba Bal, Nasma Anjrini, Meryem Zeroual
Royal Society of Chemistry eBooks (2024), pp. 41-75
Closed Access
The protective role of anti‐parkinsonian drugs in pancreatic cancer risk: A comprehensive case–control study in Taiwan
Hsuan‐Chia Yang, Wen‐Chi Chou, Phung‐Anh Nguyen, et al.
Cancer Science (2024)
Closed Access
Hsuan‐Chia Yang, Wen‐Chi Chou, Phung‐Anh Nguyen, et al.
Cancer Science (2024)
Closed Access
New targets for old drugs
Navanath Kumbhar, M.A. Aparna, Snehal K. Nimal, et al.
Elsevier eBooks (2023), pp. 315-349
Closed Access | Times Cited: 1
Navanath Kumbhar, M.A. Aparna, Snehal K. Nimal, et al.
Elsevier eBooks (2023), pp. 315-349
Closed Access | Times Cited: 1
Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Drug Repurposing of Adapalene for Melanoma Treatment
Maricruz Anaya-Ruı́z, Martín Pérez-Santos
Pharmaceutical Patent Analyst (2022) Vol. 11, Iss. 1, pp. 9-14
Closed Access | Times Cited: 2
Maricruz Anaya-Ruı́z, Martín Pérez-Santos
Pharmaceutical Patent Analyst (2022) Vol. 11, Iss. 1, pp. 9-14
Closed Access | Times Cited: 2
